Sativa Investments PLC 100% purchase of PhytoVista Laboratories
Mike Harlington, Chairman of the CTA, said: “Batch testing of product is a vital part of our industry. On behalf of our members we look forward to working with the
Mike Harlington, Chairman of the CTA, said: “Batch testing of product is a vital part of our industry. On behalf of our members we look forward to working with the
High blood pressure risk could be reduced by making changes in diet and lifestyle. Could taking CBD oil supplements help to lower the risk of hypertension symptoms? This is how
Galveston resident Trysten Pearson, who has epilepsy, experienced his first seizure in 2013 when he was 12 years old. Last summer, his mother Shena Pearson explained, his condition began to
The U.S. Food and Drug Administration have approved the use of a drug derived from marijuana for the first time Monday, giving the go ahead to treat two rare forms
Sativa Investments’ Geremy Thomas discusses the appointment of Sir Breckenridge, share price movement, GM resolutions, their George Botanicals investment and how Sativa Foundation plays a role in Sativa’s own growth in this exclusive interview with DirectorsTalk
For me, having cannabis in the evening is the equivalent of having a glass of wine on a Friday night. “People of my generation see cannabis safer than drinking and
Sativa Investments Plc (NEX:SATI) CEO Geremy Thomas talks to DirectorsTalk about the Appointment of Sir Breckenridge to the advisory board, share price movement, resolutions at GM, what George Botanicals brings
Once it had a reputation as only being used by those who were seriously ill, but cannabis oil is becoming more mainstream. Cannabidiol, or CDB, might be worth considering for
Sativa Investments PLC (LON:SATI), the UK’s only medicinal cannabis investment vehicle, has formed the Sativa Foundation to fund academic research into medicinal cannabis and its benefits to the pharmaceutical and
Sativa Investments PLC (LON:SATI), the UK’s only medicinal cannabis investment vehicle, has agreed to purchase, for £415,000, 100 per cent of George Botanicals Ltd, a UK-based manufacturer, wholesaler and distributor